The potential of PLISA was tested by the detection of humanserum albumin (HSA), a biomarker of kidney damage when found in urine,and prostate-specific antigen (PSA), a key serum biomarker of prostatecancer. The gene discussed is KLK3; the disease is Nephropathy.